Loading...
Search
Build relationsships.
Join real people.
You are not alone.
Your data stays inside.
Now it is your turn.

EASTBIO: Comparing disease resilience in wild and domestic animals using stem cell technologies at the University of Edinburgh

Details

Date & time Nov 28 '21
Ends on Dec 5 '21
Location
The University of Edinburgh, United Kingdom
Creator fbergstrom
Category job-position-vacancy

Who's attending

fbergstrom Basic

Description

Supervisors:

Tom Burdon, Helen Crooke (Animal and Plant Health Agency)


Registration website


Transmission of infectious disease between wild and domestic species is a major concern for agriculture, wild life management, and human health - as demonstrated by recent global pandemics. The overall aim of this project is to generate appropriate host cell types from disease resilient and susceptible animals using stem cell technologies, to study and compare host-pathogen interactions in different species. An advantage of the stem cell-based platform is that it can deliver an unlimited supply of differentiated cells without requiring repeated sampling from animals (of course impractical and unethical in wild animals), and is readily amenable to CRISPR/Cas9 gene editing techniques. This approach provides new opportunities to investigate how host genetics and molecular biology influence disease in the biologically appropriate genetic backgrounds (Meek et al., 2021)1.


Our experimental system is founded on the different responses of domestic and wild African pigs to African swine fever virus (ASFV).  In wild African pigs ASFV is endemic and causes no discernible disease. By contrast, in domestic pigs ASFV infection causes a lethal haemorrhagic fever that results in death within 7-10 days. In the absence of commercially available vaccines, attempts to curb the spread of ASFV in a recent ASF disease outbreak in eastern Europe and Asia resulted in the slaughter of millions of domestic pigs (https://www.bbc.co.uk/news/world-asia-48785965). ASFV therefore represents a serious and ongoing threat to global food security and animal welfare.


The macrophage is the primary cellular host for ASFV.  Deregulation and destruction of this key mediator of innate immunity by ASFV infection leads to a “cytokine storm” that causes uncontrolled inflammation and breakdown of vasculature.  We have developed a stem cell-based system that produces macrophages in culture from both domestic and African wild pigs, and have initiated studies into their differing responses to ASFV. The student will study host tolerance by comparing the response of the domestic and wild pig macrophages to infection by viruses. The project will entail analysis of transcriptional data sets, propagation and gene editing stem cells, and functional analysis of responses to ASFV in domestic and wild pig macrophages. 

This project aligns closely with the 3Rs ethos - reducing, refining and replacing animals in research (https://mrcvs.co.uk/en/news-story.php?id=19667).



References


Meek, S. et al. Stem cell-derived macrophages as a new platform for studying host-pathogen interactions in livestock.

bioRxiv 2021.09.10.459580 (2021). doi:10.1101/2021.09.10.459580


Funding information and application procedures





  • Please send your completed EASTBIO Application Form along with a copy of your academic transcripts to [email protected]


  • You should also ensure that two references have been send to [email protected]  by the deadline using the EASTBIO Reference Form


This opportunity is open to UK and international students and provides funding covering stipend and UK level tuition fees.  The University of Edinburgh covers the difference between home and international fees meaning that the EASTBIO DTP offers fully-funded studentships to all appointees.


There is a cap on the number of international students the DTP recruits.  It is therefore important for us to know from the outset which fees status category applicants will fall under when applying to our university.


Please refer to UKRI websiteand Annex B of the UKRI Training Grant Terms and Conditionsfor full eligibility criteria.



Closing Date: 16th December 2021

The Wall

No comments yet
You need to log in to comment
advertisement
Password protected photo
Password protected photo
Password protected photo